Karl Bayer

2.0k total citations
52 papers, 1.6k citations indexed

About

Karl Bayer is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Karl Bayer has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 15 papers in Genetics and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Karl Bayer's work include Viral Infectious Diseases and Gene Expression in Insects (17 papers), Bacterial Genetics and Biotechnology (13 papers) and Protein purification and stability (10 papers). Karl Bayer is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (17 papers), Bacterial Genetics and Biotechnology (13 papers) and Protein purification and stability (10 papers). Karl Bayer collaborates with scholars based in Austria, United States and Sweden. Karl Bayer's co-authors include Gerald Striedner, Monika Cserjan‐Puschmann, Reingard Grabherr, Karoline Marisch, Kurt C. Marsden, Reed C. Carroll, Guido Rossi, Tiziana Di Matola, Anna Lina Cavallo and Mario Vitale and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Neuron.

In The Last Decade

Karl Bayer

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karl Bayer Austria	22	1.2k	263	218	196	125	52	1.6k
Ana P. Teixeira Portugal	27	1.4k 1.2×	191 0.7×	168 0.8×	458 2.3×	84 0.7×	72	2.0k
M. Jordan Switzerland	8	1.1k 0.9×	259 1.0×	108 0.5×	298 1.5×	72 0.6×	15	1.6k
K. V. Venkatesh India	25	1.4k 1.2×	237 0.9×	84 0.4×	423 2.2×	14 0.1×	117	1.9k
Masatoshi Taniguchi Japan	29	1.8k 1.5×	67 0.3×	220 1.0×	72 0.4×	53 0.4×	59	3.3k
H. Satoh Japan	27	1.1k 0.9×	241 0.9×	276 1.3×	317 1.6×	55 0.4×	85	2.7k
Evan M. Zhao United States	12	1.1k 0.9×	81 0.3×	258 1.2×	410 2.1×	55 0.4×	13	1.4k
ChangWoo Lee South Korea	18	632 0.5×	72 0.3×	129 0.6×	102 0.5×	36 0.3×	77	1.3k
Enzo Martegani Italy	33	3.1k 2.6×	268 1.0×	246 1.1×	464 2.4×	40 0.3×	166	3.7k
Shuai Gao China	28	1.8k 1.5×	94 0.4×	240 1.1×	62 0.3×	47 0.4×	94	2.4k
Wei Niu United States	30	2.9k 2.4×	429 1.6×	49 0.2×	1.0k 5.2×	89 0.7×	101	3.6k

Countries citing papers authored by Karl Bayer

Since Specialization

Citations

This map shows the geographic impact of Karl Bayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Bayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Bayer more than expected).

Fields of papers citing papers by Karl Bayer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Bayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Bayer. The network helps show where Karl Bayer may publish in the future.

Co-authorship network of co-authors of Karl Bayer

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Bayer. A scholar is included among the top collaborators of Karl Bayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Bayer. Karl Bayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bayer, Karl. (2014). Brief note on the development of biotechnology.. Food Technology and Biotechnology. 52(1). 13–15. 3 indexed citations

Coultrap, Steven J., Vincent Zaegel, & Karl Bayer. (2014). CaMKII isoforms differ in their specific requirements for regulation by nitric oxide. FEBS Letters. 588(24). 4672–4676. 14 indexed citations

Marisch, Karoline, et al.. (2013). Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during high-level SOD protein production. Microbial Cell Factories. 12(1). 58–58. 75 indexed citations

Marisch, Karoline, Karl Bayer, Theresa Scharl, et al.. (2013). A Comparative Analysis of Industrial Escherichia coli K–12 and B Strains in High-Glucose Batch Cultivations on Process-, Transcriptome- and Proteome Level. PLoS ONE. 8(8). e70516–e70516. 78 indexed citations

Barcomb, Kelsey, Steven J. Coultrap, & Karl Bayer. (2013). Enzymatic Activity of CaMKII Is Not Required for Its Interaction with the Glutamate Receptor Subunit GluN2B. Molecular Pharmacology. 84(6). 834–843. 20 indexed citations

Gutmann, R A, Karl Bayer, Jürgen Dunkl, et al.. (2012). Implementation of proton transfer reaction‐mass spectrometry (PTR‐MS) for advanced bioprocess monitoring. Biotechnology and Bioengineering. 109(12). 3059–3069. 40 indexed citations

Schwanninger, Manfred, et al.. (2008). Impact of different cultivation and induction regimes on the structure of cytosolic inclusion bodies of TEM1‐β‐lactamase. Biotechnology Journal. 3(9-10). 1245–1255. 16 indexed citations

Schmidt‐Heck, Wolfgang, et al.. (2008). Monitoring of transcriptome and proteome profiles to investigate the cellular response of E. coli towards recombinant protein expression under defined chemostat conditions. Journal of Biotechnology. 135(1). 34–44. 42 indexed citations

Mairhofer, Juergen, et al.. (2006). Using ColE1‐derived RNA I for suppression of a bacterially encoded gene: implication for a novel plasmid addiction system. Biotechnology Journal. 1(6). 675–681. 18 indexed citations

10.

Bayer, Karl, et al.. (2006). Improvement of bioprocess monitoring: development of novel concepts. Microbial Cell Factories. 5(1). 19–19. 90 indexed citations

11.

Striedner, Gerald, et al.. (2003). Tuning the Transcription Rate of Recombinant Protein in Strong Escherichiacoli Expression Systems through Repressor Titration. Biotechnology Progress. 19(5). 1427–1432. 71 indexed citations

12.

Marzban, Gorji, et al.. (2003). Monitoring of protein profiles for the optimization of recombinant fermentation processes using public domain databases. Electrophoresis. 24(1-2). 303–310. 17 indexed citations

13.

Grabherr, Reingard & Karl Bayer. (2002). Impact of targeted vector design on ColE1 plasmid replication. Trends in biotechnology. 20(6). 257–260. 31 indexed citations

14.

Grabherr, Reingard, Erik Nilsson, Gerald Striedner, & Karl Bayer. (2001). Stabilizing plasmid copy number to improve recombinant protein production. Biotechnology and Bioengineering. 77(2). 142–147. 52 indexed citations

15.

Marzban, Gorji, et al.. (1998). Off‐line quantitative monitoring of plasmid copy number in bacterial fermentation by capillary electrophoresis. Electrophoresis. 19(14). 2474–2478. 19 indexed citations

16.

Weik, Robert, et al.. (1996). Kinetic Studies for the Optimization of Recombinant Protein Formationa. Annals of the New York Academy of Sciences. 782(1). 323–333. 29 indexed citations

17.

Cıcero, Marcus Tullius, et al.. (1994). Partitiones Oratoriae = Rhetorik in Frage und Antwort.

18.

Bayer, Karl. (1993). Nota bene! : das lateinische Zitatenlexikon. 2 indexed citations

19.

Kulicke, Marianne & Karl Bayer. (1993). Chancen und Risiken junger Technologieunternehmen : Ergebnisse des Modellversuchs "Förderung technologieorientierter Unternehmensgründungen". Physica-Verlag eBooks. 14 indexed citations

20.

Sophocles, et al.. (1966). Tragödien und Fragmente.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact